EYE vs. STVN, GKOS, NARI, IRTC, TMDX, BLCO, INSP, SLNO, PRCT, and NVST
Should you be buying National Vision stock or one of its competitors? The main competitors of National Vision include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), iRhythm Technologies (IRTC), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Soleno Therapeutics (SLNO), PROCEPT BioRobotics (PRCT), and Envista (NVST). These companies are all part of the "medical equipment" industry.
National Vision vs.
Stevanato Group (NYSE:STVN) and National Vision (NASDAQ:EYE) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership, community ranking, media sentiment and profitability.
Stevanato Group has higher earnings, but lower revenue than National Vision. National Vision is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Stevanato Group and Stevanato Group both had 6 articles in the media. National Vision's average media sentiment score of 1.11 beat Stevanato Group's score of 1.03 indicating that National Vision is being referred to more favorably in the news media.
National Vision received 227 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 64.50% of users gave National Vision an outperform vote while only 63.27% of users gave Stevanato Group an outperform vote.
Stevanato Group has a beta of 0.53, suggesting that its stock price is 47% less volatile than the S&P 500. Comparatively, National Vision has a beta of 1.24, suggesting that its stock price is 24% more volatile than the S&P 500.
National Vision has a consensus target price of $17.75, indicating a potential downside of 15.56%. Given National Vision's higher probable upside, analysts plainly believe National Vision is more favorable than Stevanato Group.
Stevanato Group has a net margin of 10.47% compared to National Vision's net margin of -0.81%. Stevanato Group's return on equity of 9.86% beat National Vision's return on equity.
Summary
Stevanato Group beats National Vision on 9 of the 15 factors compared between the two stocks.
Get National Vision News Delivered to You Automatically
Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
National Vision Competitors List
Related Companies and Tools
This page (NASDAQ:EYE) was last updated on 6/11/2025 by MarketBeat.com Staff